Ulcerative colitis resident survival guide: Difference between revisions
No edit summary |
No edit summary |
||
Line 15: | Line 15: | ||
{{Family tree/start}} | {{Family tree/start}} | ||
{{familytree | | | | | | | | | | | | | | | | | | A01 | | | | | | | | | | | | | | A01= <div style="float: left; text-align: left; height: 42em; width: 27em; padding:1em;"> '''Characterize the symptoms:'''<br> | {{familytree | | | | | | | | | | | | | | | | | | | | A01 | | | | | | | | | | | | | | A01= <div style="float: left; text-align: left; height: 42em; width: 27em; padding:1em;"> '''Characterize the symptoms:'''<br> | ||
---- | ---- | ||
❑ [[Diarrhea]] (onset, duration, pattern, frequency, type) <br> | ❑ [[Diarrhea]] (onset, duration, pattern, frequency, type) <br> | ||
Line 45: | Line 45: | ||
❑ Family H/O <br> | ❑ Family H/O <br> | ||
❑ Systemic illness H/O <br> </div>}} | ❑ Systemic illness H/O <br> </div>}} | ||
{{familytree | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | |}} | {{familytree | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | |}} | ||
{{familytree | | | | | | | | | | | | | | | | | | B01 | | | | | | | | | | | | | | | | | | | | | | | B01=<div style="float: left; text-align: left; height: 25em; width: 25em; padding:1em;">'''Assess volume status:''' | {{familytree | | | | | | | | | | | | | | | | | | | | B01 | | | | | | | | | | | | | | | | | | | | | | | B01=<div style="float: left; text-align: left; height: 25em; width: 25em; padding:1em;">'''Assess volume status:''' | ||
---- | ---- | ||
❑ General condition <br> | ❑ General condition <br> | ||
Line 58: | Line 58: | ||
---- | ---- | ||
❑ Skin (swelling, pain, erythema or ulceration) <br> ❑ Abdomen (mass, distension or tenderness) <br> ❑ Respiratory system (wheezing or crackles) <br> ❑ Cardiovascular system <br> ❑ Anorectal (bleeding) <br> ❑ Eye (swelling, pain, edema or vision loss) <br> ❑ Musculoskeletal (Axial, large and small joints) <br> </div>}} | ❑ Skin (swelling, pain, erythema or ulceration) <br> ❑ Abdomen (mass, distension or tenderness) <br> ❑ Respiratory system (wheezing or crackles) <br> ❑ Cardiovascular system <br> ❑ Anorectal (bleeding) <br> ❑ Eye (swelling, pain, edema or vision loss) <br> ❑ Musculoskeletal (Axial, large and small joints) <br> </div>}} | ||
{{familytree | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | }} | {{familytree | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | }} | ||
{{familytree | | | | | | | | | | | | | | | | | | C01 | | | | | | | | | | | | | | | | | | | | | C01= <div style="float: left; text-align: left; height: 23em; width: 25em; padding:1em;">'''Order tests:'''<br> | {{familytree | | | | | | | | | | | | | | | | | | | | C01 | | | | | | | | | | | | | | | | | | | | | C01= <div style="float: left; text-align: left; height: 23em; width: 25em; padding:1em;">'''Order tests:'''<br> | ||
❑ [[Complete blood count|Complete blood count (CBC)]] <br> | ❑ [[Complete blood count|Complete blood count (CBC)]] <br> | ||
❑ [[Erythrocyte sedimentation rate|Erythrocyte sedimentation rate (ESR)]]<br> | ❑ [[Erythrocyte sedimentation rate|Erythrocyte sedimentation rate (ESR)]]<br> | ||
Line 74: | Line 74: | ||
❑ STD's: [[VDRL]], [[PCR]] ([[HSV]]), gonococcal culture <br> | ❑ STD's: [[VDRL]], [[PCR]] ([[HSV]]), gonococcal culture <br> | ||
</div>}} | </div>}} | ||
{{familytree | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | |}} | {{familytree | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | |}} | ||
{{familytree | | | | | | | | | | | | | | | | | | D10 | | | | | | | | | | | | | | | | | | | | | | D10= <div style="float: left; text-align: left"> '''Confirmatory diagnostic tests:'''<br> ❑ [[Colonoscopy|Colonoscopy and biopsy]] <br> ❑ [[Proctosigmoidoscopy|Proctosigmoidoscopy and biopsy]] <br> ❑ Ileocolonoscopy <br> ❑ [[Computed tomography|Computed tomography (CT)]] <br> ❑ [[Barium enema]] <br> ❑ [[Magnetic resonance imaging]] <br> | {{familytree | | | | | | | | | | | | | | | | | | | | D10 | | | | | | | | | | | | | | | | | | | | | | D10= <div style="float: left; text-align: left"> '''Confirmatory diagnostic tests:'''<br> ❑ [[Colonoscopy|Colonoscopy and biopsy]] <br> ❑ [[Proctosigmoidoscopy|Proctosigmoidoscopy and biopsy]] <br> ❑ Ileocolonoscopy <br> ❑ [[Computed tomography|Computed tomography (CT)]] <br> ❑ [[Barium enema]] <br> ❑ [[Magnetic resonance imaging]] <br> | ||
</div>}} | </div>}} | ||
{{familytree | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | |}} | {{familytree | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | |}} | ||
{{familytree | | | | | | | | | | | | | | | | | | D10 | | | | | | | | | | | | | | | | | | | | | | D10= <div style="float: left; text-align: left"> '''Findings suggestive of Crohn's disease:'''<br> ❑ Symmetric, continuous, and circumferential lesions <br> ❑ Biopsy (Mucosal inflammation, noncaseating granuloma, villous atrophy, crypt abscess) <br> ❑ Rectum involvement (95%) <br> ❑ Backwash ileitis <br> ❑ Negative stool examination for infectious causes <br> | {{familytree | | | | | | | | | | | | | | | | | | D10 | | | | | | | | | | | | | | | | | | | | | | D10= <div style="float: left; text-align: left"> '''Findings suggestive of Crohn's disease:'''<br> ❑ Symmetric, continuous, and circumferential lesions <br> ❑ Biopsy (Mucosal inflammation, noncaseating granuloma, villous atrophy, crypt abscess) <br> ❑ Rectum involvement (95%) <br> ❑ Backwash ileitis <br> ❑ Negative stool examination for infectious causes <br> | ||
</div>}} | </div>}} | ||
{{familytree | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | |}} | {{familytree | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | |}} | ||
{{familytree | | | | | | | | | | | | | | | | | | B01 | | | B01=Assessment of severity}} | {{familytree | | | | | | | | | | | | | | | | | | | | B01 | | | B01=Assessment of severity}} | ||
{{familytree | | | | | | |,|-|-|-|-|-|-|-|-|-|-|-|+|-|-|-|-|-|-|-|-|-|-|.| | | | | | | | | | | |}} | {{familytree | | | | | | | | |,|-|-|-|-|-|-|-|-|-|-|-|+|-|-|-|-|-|-|-|-|-|-|.| | | | | | | | | | | |}} | ||
{{familytree | | | | | | C01 | | | | | | | | | | C02 | | | | | | | | | C03 | | | | | | | | | | | | C01= <div style="float: left; text-align: left">'''Mild''' | {{familytree | | | | | | | | C01 | | | | | | | | | | C02 | | | | | | | | | C03 | | | | | | | | | | | | C01= <div style="float: left; text-align: left">'''Mild''' | ||
---- | ---- | ||
❑ < 4 loose stools per day (+/- blood) <br> | ❑ < 4 loose stools per day (+/- blood) <br> | ||
Line 112: | Line 112: | ||
❑ Rapid weight loss <br> | ❑ Rapid weight loss <br> | ||
</div>}} | </div>}} | ||
{{familytree | | | | |,|-|-|-|^|-|-|-|.| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{familytree | | | | A01 | | | | | | A02 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |A01=Distal 5-8 cm of the [[rectum]] | A02=Greater than 8 cm of distal [[rectum]]}} | |||
{{familytree | | | | |!| | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{familytree | | | | B01 | | | | | | B02 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |B01=<div style="float: left; text-align: left">'''Topical (rectal) [[5-aminosalicylic acid]] (5-ASA)''' | |||
---- | |||
❑ [[Mesalamine]] [[suppositories]]: 500 mg BID or 1 g OD <br> | |||
---- | |||
'''OR''' <br> | |||
---- | |||
Consider '''Topical (rectal) [[steroids]]''' | |||
---- | |||
❑ [[Hydrocortisone]] suppository: 30 mg BID <br> | |||
</div> | |||
| B02=<div style="float: left; text-align: left">'''Topical (rectal) [[5-aminosalicylic acid]] (5-ASA)''' | |||
---- | |||
❑ [[Mesalamine]] [[enemas]]: 1-4 g BID <br> | |||
'''PLUS'''<br> | |||
❑ [[Mesalamine]] [[suppositories]]: 500 mg BID or 1 g OD <br> | |||
---- | |||
'''OR''' <br> | |||
---- | |||
Consider '''Topical (rectal) [[steroids]]''' | |||
---- | |||
❑ [[Hydrocortisone]] [[enema]]/[[foam]]: 100 mg BID<br> | |||
'''PLUS'''<br> | |||
❑ [[Hydrocortisone]] [[suppository]]: 30 mg BID <br> | |||
</div> | |||
}} | |||
{{familytree | | | | |!| | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{familytree | | | | C01 | | | | | | C02 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |C01= Response in 4-6 wks | C02=Response in 4-6 wks}} | |||
{{familytree | | |,|-|^|-|.| | | |,|-|^|-|.| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{familytree | | C01 | | C02 | | C03 | | C04 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |C01=Yes|C02=No|C03=No|C04=Yes}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | {{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | ||
{{Family tree/end}} | {{Family tree/end}} |
Revision as of 17:59, 20 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mugilan Poongkunran M.B.B.S [2]
Definition
Ulcerative colitis (UC) is a chronic disease characterized by recurring episodes of diffuse inflammation limited to the mucosal layer of the colon, presenting prominently as bloody diarrhea with rectal urgency and tenesmus. It commonly involves the rectum and may extend proximally in a symmetrical, circumferential, and uninterrupted pattern to involve parts or all of the large intestine.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. Crohn’s disease itself may present or complicate as a life-threatening condition and must be treated as such irrespective of the causes.
Common Causes
Management
The algorithm is based on the American Journal of Gastroenterology guidelines for management of Ulcerative colitis (UC) disease in adults.
Characterize the symptoms: ❑ Diarrhea (onset, duration, pattern, frequency, type) Extraintestinal symptoms: ❑ Skin lesions Obtain detailed history: ❑ Recent travel H/O | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Assess volume status:
❑ General condition Examine the patient: ❑ Skin (swelling, pain, erythema or ulceration) ❑ Abdomen (mass, distension or tenderness) ❑ Respiratory system (wheezing or crackles) ❑ Cardiovascular system ❑ Anorectal (bleeding) ❑ Eye (swelling, pain, edema or vision loss) ❑ Musculoskeletal (Axial, large and small joints) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Order tests: ❑ Complete blood count (CBC) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Confirmatory diagnostic tests: ❑ Colonoscopy and biopsy ❑ Proctosigmoidoscopy and biopsy ❑ Ileocolonoscopy ❑ Computed tomography (CT) ❑ Barium enema ❑ Magnetic resonance imaging | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Findings suggestive of Crohn's disease: ❑ Symmetric, continuous, and circumferential lesions ❑ Biopsy (Mucosal inflammation, noncaseating granuloma, villous atrophy, crypt abscess) ❑ Rectum involvement (95%) ❑ Backwash ileitis ❑ Negative stool examination for infectious causes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Assessment of severity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mild
❑ < 4 loose stools per day (+/- blood) | Severe
❑ ≥6 loose bloody stools per day | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Distal 5-8 cm of the rectum | Greater than 8 cm of distal rectum | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Topical (rectal) 5-aminosalicylic acid (5-ASA)
❑ Mesalamine suppositories: 500 mg BID or 1 g OD OR Consider Topical (rectal) steroids ❑ Hydrocortisone suppository: 30 mg BID | Topical (rectal) 5-aminosalicylic acid (5-ASA)
❑ Mesalamine enemas: 1-4 g BID OR Consider Topical (rectal) steroids ❑ Hydrocortisone enema/foam: 100 mg BID | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Response in 4-6 wks | Response in 4-6 wks | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | No | Yes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||